Literature DB >> 18483341

Helicobacter pylori infection and development of pancreatic cancer.

Catherine de Martel1, Augusto E Llosa, Gary D Friedman, Gary D Friedmana, Joseph H Vogelman, Norman Orentreich, Rachael Z Stolzenberg-Solomon, Julie Parsonnet.   

Abstract

BACKGROUND: Infection with Helicobacter pylori is an established risk factor for gastric cancer. Results from two studies suggest that it may also be a risk factor for pancreatic cancer.
METHODS: We conducted a nested case control study among 128,992 adult subscribers to the Kaiser Permanente Medical Care Program who had been enrolled in a multiphasic health checkup from 1964 to 1969. Serum collected during the checkup was maintained frozen, and subjects were followed for cancer. Cases consisted of 104 randomly selected subjects among 507 who developed pancreatic cancer in the cohort. Controls consisted of 262 pancreatic cancer-free subjects from a pool of 730 controls previously tested for studies conducted on this cohort. Controls were individually matched to cases on age, gender, race, site, and date of multiphasic health checkup. Control sera were compared with cases for antibodies to H. pylori and the CagA protein. The effects of smoking, alcohol consumption, obesity, and years of education were also investigated.
RESULTS: Neither H. pylori [odds ratio (OR), 0.85; 95% confidence interval (95% CI), 0.49-1.48] nor its CagA protein (OR, 0.96; 95% CI, 0.48-1.92) was associated with subsequent development of pancreatic cancer. Smoking (OR, 2.09; 95% CI, 1.17-3.74) and greater number of years of education (OR, 2.13; 95% CI, 1.23-3.69) were risk factors for pancreatic cancer, whereas alcohol consumption and obesity were not.
CONCLUSION: Our results suggest that H. pylori infection is not associated with development of pancreatic cancer.

Entities:  

Mesh:

Year:  2008        PMID: 18483341     DOI: 10.1158/1055-9965.EPI-08-0185

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  25 in total

Review 1.  Microbiota, oral microbiome, and pancreatic cancer.

Authors:  Dominique S Michaud; Jacques Izard
Journal:  Cancer J       Date:  2014 May-Jun       Impact factor: 3.360

2.  Cigarette smoking and the risk of pancreatic cancer: a case-control study.

Authors:  Yue Wang; Hong Duan; Xiaowan Yang; Junxi Guo
Journal:  Med Oncol       Date:  2014-08-27       Impact factor: 3.064

Review 3.  Helicobacter pylori and pancreatic diseases.

Authors:  Milutin Bulajic; Nikola Panic; Johannes Matthias Löhr
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15

4.  ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case-control study.

Authors:  Harvey A Risch; Herbert Yu; Lingeng Lu; Mark S Kidd
Journal:  J Natl Cancer Inst       Date:  2010-02-24       Impact factor: 13.506

5.  Helicobacter pylori infection, atrophic gastritis, and risk of pancreatic cancer: A population-based cohort study in a large Japanese population: the JPHC Study.

Authors:  Mayo Hirabayashi; Manami Inoue; Norie Sawada; Eiko Saito; Sarah K Abe; Akihisa Hidaka; Motoki Iwasaki; Taiki Yamaji; Taichi Shimazu; Shoichiro Tsugane
Journal:  Sci Rep       Date:  2019-04-15       Impact factor: 4.379

6.  Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer.

Authors:  James J Farrell; Lei Zhang; Hui Zhou; David Chia; David Elashoff; David Akin; Bruce J Paster; Kaumudi Joshipura; David T W Wong
Journal:  Gut       Date:  2011-10-12       Impact factor: 23.059

Review 7.  Microbiome and potential targets for chemoprevention of esophageal adenocarcinoma.

Authors:  Antonio Galvao Neto; April Whitaker; Zhiheng Pei
Journal:  Semin Oncol       Date:  2015-09-07       Impact factor: 4.929

8.  Seropositivity to Helicobacter pylori and risk of pancreatic cancer.

Authors:  Guoqin Yu; Gwen Murphy; Angelika Michel; Stephanie J Weinstein; Satu Männistö; Demetrius Albanes; Michael Pawlita; Rachael Z Stolzenberg-Solomon
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-10-02       Impact factor: 4.254

9.  Serum pepsinogen level, atrophic gastritis and the risk of incident pancreatic cancer--a prospective cohort study.

Authors:  Adeyinka O Laiyemo; Farin Kamangar; Pamela M Marcus; Philip R Taylor; Jarmo Virtamo; Demetrius Albanes; Rachael Z Stolzenberg-Solomon
Journal:  Cancer Epidemiol       Date:  2009-10-01       Impact factor: 2.984

Review 10.  Role of bacterial infections in pancreatic cancer.

Authors:  Dominique S Michaud
Journal:  Carcinogenesis       Date:  2013-07-10       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.